BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6988265)

  • 1. Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.
    Fineberg SE; Schneider SH
    Diabetologia; 1980 Jan; 18(1):49-54. PubMed ID: 6988265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus.
    Groop L; Tötterman KJ
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):410-5. PubMed ID: 7051722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in patients with insulin independent diabetes mellitus: partial amelioration by the sulfonylurea glipizide.
    Lebovitz H; Feinglos MN
    Adv Exp Med Biol; 1979; 119():371-9. PubMed ID: 495293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glibenclamide and glipizide in maturity onset diabetes. A double-blind cross-over study.
    Blohmé G; Waldenström J
    Acta Med Scand; 1979; 206(4):263-7. PubMed ID: 116480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide.
    Lecomte MJ; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1977 Dec; 3(4):239-43. PubMed ID: 340296
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of a new sulfonylurea in maturity onset diabetes - glipizide (K-4024).
    Bandisode MS; Boshell BR
    Horm Metab Res; 1976 Mar; 8(2):89-91. PubMed ID: 770300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glipizide ('Glibenese') in maturity-onset diabetes mellitus.
    Klaassen CH
    Curr Med Res Opin; 1979; 6(1):8-13. PubMed ID: 378559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients.
    Sartor G; Scherstén B; Melander A
    Acta Med Scand; 1978; 203(3):211-4. PubMed ID: 345754
    [No Abstract]   [Full Text] [Related]  

  • 10. Glipizide in the treatment of maturity-onset diabetes: a multi-centre, out-patient study.
    Fowler LK
    Curr Med Res Opin; 1978; 5(5):418-23. PubMed ID: 350493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and efficacy of glipizide.
    Feinglos MN; Lebovitz HE
    Am J Med; 1983 Nov; 75(5B):60-6. PubMed ID: 6369969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus.
    Greenfield MS; Doberne L; Rosenthal M; Schulz B; Widstrom A; Reaven GM
    Diabetes; 1982 Apr; 31(4 Pt 1):307-12. PubMed ID: 6759246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glipizide versus tolbutamide in maturity-onset diabetes, an open comparative study.
    Fuchs K
    Diabetologia; 1973 Sep; ():351-5. PubMed ID: 4772980
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients.
    Bonora E; Pisani F; Micciolo R; Corgnati A; Muggeo M
    Diabetes Care; 1987; 10(6):687-91. PubMed ID: 3322723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of glucose and lactate after intravenous glipizide administration in some insulin-dependent diabetics. Therapeutic effects of an associated glipizide-insulin treatment.
    Giampietro O; Navalesi R; Buzzigoli G; Boni C
    Curr Med Res Opin; 1979; 6(5):325-30. PubMed ID: 396109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
    Khandekar S; Sethi BK; Dash RJ
    J Assoc Physicians India; 1990 Jul; 38(7):469-71. PubMed ID: 2127273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs.
    Lebovitz HE; Feinglos MN; Bucholtz HK; Lebovitz FL
    J Clin Endocrinol Metab; 1977 Sep; 45(3):601-4. PubMed ID: 903405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of treatment with glipizide-metformin on the behavior of blood sugar, insulin and lipids after intravenous administration of glucose in diabetic subjects].
    Ferlito S; Lunetta M; Mangiagli P; Tranchida ML
    G Clin Med; 1974 Nov; 55(11):798-818. PubMed ID: 4469884
    [No Abstract]   [Full Text] [Related]  

  • 20. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.